ProShares Ultra NASDAQ Biotechnology
BIB
BIB
31 hedge funds and large institutions have $21M invested in ProShares Ultra NASDAQ Biotechnology in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 14
Holders
31
Holding in Top 10
–
Calls
$21.1M
Puts
$16.4M
Top Buyers
| 1 | +$1.74M | |
| 2 | +$961K | |
| 3 | +$661K | |
| 4 |
CT
CMT Trading
Chicago,
Illinois
|
+$571K |
| 5 |
HF
HRT Financial
New York
|
+$376K |
Top Sellers
| 1 | -$2.63M | |
| 2 | -$2.01M | |
| 3 | -$1.3M | |
| 4 |
LPL Financial
San Diego,
California
|
-$788K |
| 5 |
Jane Street
New York
|
-$474K |